The Distribution, Frequency and Type of Hepatobiliary Complications.

Center A. Placebo: allograft dysfunction (1), primary graft non-function (1), reduced portal vein flow (1), hepatic artery bleeding (2). iNO: allograft dysfunction (1), hepatic artery bleeding (1). Center B. Placebo: 1-month:primary graft dysfunction (1), reduced hepatic artery blood flow (1), biliary leak (1), 6-months:biliary stricture (2), 9-months:rejection (1), hepatic artery stenosis (1), death (1). iNO: 9-months:hepatic artery stenosis (1), death (1).